Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, glucosuria, or irritation occurs. Use lowest effective dose and potency (esp. in children).

The US Food and Drug Administration (FDA) has approved a new indication for osilodrostat (Isturisa, Recordati) as second-line treatment of endogenous hypercortisolemia in adults with Cushing syndrome.

Looking back at Texas A&M's best offensive lines over the last two decades, one O-line coach has consistently stood out outside of current mainstay Adam Cushing, who followed head coach Mike Elko ...